ADA Scientific Sessions 2026 Abstract
Combination Treatment of Oral Small Molecule GLP-1 Receptor Agonist Aleniglipron and Small Molecule Amylin Receptor Agonist ACCG-2671 Demonstrated Additional Weight Loss than Monotreatment in Obese NHPs
Experiments in animalsInterventions
The paper
South San Francisco
ADA Scientific Sessions 2026 Abstract, 5 Jun 2026
Presented at ADA Scientific Sessions 2026, late-breaking 3061-LB
